13,732 Shares in Medtronic PLC $MDT Acquired by Applied Finance Capital Management LLC

Applied Finance Capital Management LLC purchased a new stake in shares of Medtronic PLC (NYSE:MDT) in the third quarter, according to its most recent 13F filing with the SEC. The fund purchased 13,732 shares of the medical technology company’s stock, valued at approximately $1,308,000.

Several other institutional investors have also recently made changes to their positions in the company. Brighton Jones LLC boosted its stake in shares of Medtronic by 1,368.0% in the 4th quarter. Brighton Jones LLC now owns 39,989 shares of the medical technology company’s stock valued at $3,194,000 after purchasing an additional 37,265 shares in the last quarter. Sivia Capital Partners LLC lifted its stake in shares of Medtronic by 9.6% in the 2nd quarter. Sivia Capital Partners LLC now owns 4,356 shares of the medical technology company’s stock valued at $380,000 after acquiring an additional 381 shares during the last quarter. Concurrent Investment Advisors LLC boosted its holdings in Medtronic by 11.4% during the 2nd quarter. Concurrent Investment Advisors LLC now owns 52,948 shares of the medical technology company’s stock valued at $4,615,000 after acquiring an additional 5,408 shares during the period. Vanguard Personalized Indexing Management LLC grew its position in Medtronic by 6.8% during the 2nd quarter. Vanguard Personalized Indexing Management LLC now owns 120,034 shares of the medical technology company’s stock worth $10,464,000 after acquiring an additional 7,643 shares during the last quarter. Finally, Allspring Global Investments Holdings LLC increased its stake in Medtronic by 2.4% in the 2nd quarter. Allspring Global Investments Holdings LLC now owns 1,176,171 shares of the medical technology company’s stock worth $104,385,000 after purchasing an additional 27,055 shares during the period. Institutional investors own 82.06% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities research analysts have issued reports on MDT shares. JPMorgan Chase & Co. raised their price target on shares of Medtronic from $90.00 to $100.00 and gave the stock a “neutral” rating in a report on Thursday, November 13th. Wall Street Zen raised Medtronic from a “hold” rating to a “buy” rating in a research note on Friday, January 23rd. Weiss Ratings restated a “buy (b-)” rating on shares of Medtronic in a report on Monday, December 29th. Royal Bank Of Canada increased their price objective on Medtronic from $111.00 to $118.00 and gave the stock an “outperform” rating in a report on Wednesday, November 19th. Finally, Jefferies Financial Group reissued a “hold” rating and set a $110.00 target price on shares of Medtronic in a research note on Wednesday, November 19th. Sixteen analysts have rated the stock with a Buy rating and ten have given a Hold rating to the company. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $111.21.

Medtronic Trading Down 1.2%

Shares of NYSE:MDT opened at $101.69 on Tuesday. The company has a debt-to-equity ratio of 0.57, a current ratio of 2.42 and a quick ratio of 1.80. Medtronic PLC has a 1 year low of $79.55 and a 1 year high of $106.33. The company has a market cap of $130.37 billion, a P/E ratio of 27.41, a PEG ratio of 2.71 and a beta of 0.71. The stock’s fifty day moving average price is $99.37 and its 200-day moving average price is $96.22.

Medtronic (NYSE:MDT) last announced its earnings results on Tuesday, November 18th. The medical technology company reported $1.36 earnings per share for the quarter, beating analysts’ consensus estimates of $1.31 by $0.05. The business had revenue of $8.96 billion during the quarter, compared to analyst estimates of $8.86 billion. Medtronic had a net margin of 13.71% and a return on equity of 14.86%. The company’s quarterly revenue was up 6.6% compared to the same quarter last year. During the same period in the previous year, the business earned $1.26 EPS. Medtronic has set its FY 2026 guidance at 5.620-5.660 EPS. Sell-side analysts expect that Medtronic PLC will post 5.46 earnings per share for the current year.

Medtronic Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, January 16th. Investors of record on Friday, December 26th were given a dividend of $0.71 per share. The ex-dividend date was Friday, December 26th. This represents a $2.84 annualized dividend and a dividend yield of 2.8%. Medtronic’s dividend payout ratio (DPR) is currently 76.55%.

About Medtronic

Medtronic plc is a global medical technology company that develops and manufactures a broad range of therapeutic devices and health care solutions. Headquartered legally in Ireland with principal operational offices in the United States, the company markets products to hospitals, physicians and health systems worldwide and has grown from its founding in 1949 into one of the largest medical-device manufacturers serving global health-care markets.

Medtronic’s offerings span several clinical areas, including cardiac rhythm and heart failure (pacemakers, implantable cardioverter‑defibrillators and related cardiac therapies), minimally invasive and surgical technologies (laparoscopic and advanced energy devices, visualization systems and surgical innovations), restorative therapies (spine and orthopedics, neuromodulation and neurovascular treatments) and diabetes management (insulin-delivery systems and glucose monitoring solutions).